Please login to the form below
Latest white papers and resources on PMHub
Listed below are the latest white papers and thought leadership submitted by suppliers using PMHub to promote their services to our international pharma audience. If you would like to be included within PMHub, please click the ‘Add my Company’ link.
-
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid decentralised trials was slow. But when it became clear that existing and upcoming clinical trials wouldn’t be able to run as planned, biotech and pharma companies have been scrambling to work out how they can take their trial out of the clinic and into a virtual setting.
Submitted by: COUCH Health -
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint in this week's instalment of our Pharma and COVID-19 series by Rare Immunology Global Medical Lead Karen Cheng
Submitted by: Frontera Group -
Love in the Time of Coronavirus
Having gone through 4 stages of coping with covid-19: first disbelief, then humour, then creative ways to deal with isolation, and finally the tragic realisation that lives are being lost and our world will never be the same again.
Submitted by: Life Healthcare Communications -
Healthcare in a lockdown
Even if patients are getting enough care during the COVID-19 pandemic, are they getting the right care?
Submitted by: Frontera Group -
OPEN Health brings the Best of Both Worlds to MAPS EMEA 2020
Submitted by: OPEN Health -
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision.
Submitted by: Frontera Group -
The other side of … multiple sclerosis
No good comes from excluding patients from having a say in their own care. In fact, improving activation (& outcomes) demands it.
Submitted by: Frontera Group -
The other side of … Crohn’s disease
What patients say is their truth about living with chronic conditions. “I want to believe in my doctor but I feel more comfortable getting my guidance elsewhere.”
Submitted by: Frontera Group -
1000 Voices Survey
The patient voice is key to creating meaningful changes in healthcare; to drive patients to be more actively involved in their care, which leads to better outcomes. So, we went to patients and asked them their views on how being actively involved they are...
Submitted by: Frontera Group -
OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward
Submitted by: OPEN Health
Featured jobs
Latest content from PMHub
- Patients are ready to embrace decentralised clinical trials, are you?
- Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid decentralised trials was slow. But when it became clear that existing and upcoming clinical trials wouldn’t be able to run as planned, biotech and pharma companies have been scrambling to work out how they can take their trial out of the clinic and into a virtual setting.
COUCH Health
- Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
- The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint in this week's instalment of our Pharma and COVID-19 series by Rare Immunology Global Medical Lead Karen Cheng
Frontera Group
- Visual Storytelling in HealthTech
- In the latest episode of Impetus Digital's Fireside Chat, I sit down with Rodney Hu, founder of 209|Digital and a popular podcast host. We explore Rodney’s work within the HealthTech space and what he believes has to happen for the healthcare industry to more readily adopt new digital technologies. We also discuss how Rodney’s experiences with working as an MRI technologist and with being a patient himself have impacted on his work and vision for the future.
Impetus Digital
- Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- In the latest episode of Impetus Digital's Fireside Chat, I talk with Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals. Sandra has extensive experience working in physician, patient, and brand strategy; product marketing; digital; and KOL engagement. We discuss a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and KOLs to the challenges it has brought for healthcare marketing and sales. We also dive into the lessons learned from Sandra’s work on patient education and advocacy, and much more.
Impetus Digital
